跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diaxime 200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diaxime 200
Approved
STANDARD
Diaxime 200
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6f09cffd73b5d1d6
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
6f09cffd73b5d1d6
Drug Approval Philippines Name
Diaxime 200
Product Name
Diaxime 200
Registration Number
DRP-4051-02
Brand Name
Diaxime 200
Generic Name
Cefixime (As Trihydrate)
Dosage Form
Capsule
Dosage Strength
200 mg
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
Pharmalife Distribution
Issuance Date
28 September 2022
Expiry Date
16 October 2027
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6f09cffd73b5d1d6
Type
Standard
Back to Philippines FDA Approvals